Introduction {#section1-2050313X20919600}
============

Cutaneous sporotrichosis infections can be difficult to visually distinguish from other ulcerative or infiltrative lesions. The differential for ulcerative lesions includes infectious and non-infectious causes such as malignancies, vascular disorders, and inflammatory disorders. Sporotrichosis lesions have been misdiagnosed as ulcerative pyoderma gangrenosum (PG) due to similar clinical appearance or lack of positive culture or histological stains.^[@bibr1-2050313X20919600][@bibr2-2050313X20919600][@bibr3-2050313X20919600][@bibr4-2050313X20919600][@bibr5-2050313X20919600][@bibr6-2050313X20919600][@bibr7-2050313X20919600]--[@bibr8-2050313X20919600]^ Weenig et al.^[@bibr1-2050313X20919600]^ found that 11/64 (17%) lesions misdiagnosed as PG were caused by primary cutaneous infections, with the pathogen being *Sporothrix schenckii* in 5/11 cases. As immunosuppressive therapies are standard of care for treating PG, exclusion of infectious etiology is especially important prior to starting therapy. Updated ulcerative PG diagnostic criteria require a biopsy demonstrating neutrophilic inflammation, making diagnosis of PG no longer purely a diagnosis of exclusion.^[@bibr9-2050313X20919600]^ This case highlights the importance of exclusion of infection as a diagnostic criterion.

Here, we report a case of cutaneous sporotrichosis misdiagnosed and treated for 17 months as ulcerative PG, leading to exacerbation and atypical morphology mimicking *Histoplasma* organisms on re-biopsy.

Case report {#section2-2050313X20919600}
===========

A 78-year-old male presented with a non-healing left arm ulcer in June 2017 ([Figure 1](#fig1-2050313X20919600){ref-type="fig"}). A 5-mm punch biopsy showed extensive neutrophilic inflammation and periodic acid--Schiff (PAS) staining for fungal organisms was reported as negative, and simultaneous tissue culture was not done. The case diagnosis was compatible with PG. Various immunosuppressive treatments were tried for a year leading to worsening progression.

![View of the patient's left upper arm prior to antifungal treatment showing cribriform ulceration.](10.1177_2050313X20919600-fig1){#fig1-2050313X20919600}

The patient presented to our clinic November 2018 and was being treated with IV immunoglobulin (IVIG), prednisone, and ustekinumab for 7 months with severe disease progression. Treatment with cyclosporine and mycophenolate previously failed due to hypertension and leg swelling, and gastrointestinal disturbances, respectively. No risk factors such as environmental exposures, previous occupation, and travel were reported. Lymphangitis and lymph node involvement was not present.

A 4-mm punch biopsy of the ulcer edge showed numerous three- to four-micron intra-cytoplasmic yeasts within histiocytes ([Figure 2(a)](#fig2-2050313X20919600){ref-type="fig"}). Hundreds of intracellular organisms were PAS stain-positive and Grocott's methenamine silver stain-positive ([Figure 2(b)](#fig2-2050313X20919600){ref-type="fig"} and ([c](#fig2-2050313X20919600){ref-type="fig"})), ranging from 3 to 12 microns with some budding yeasts. Despite morphological consistency with *Histoplasmosis* *duboisii* or *capsulatum*, tissue cultures led to isolation of *S. schenckii* species complex, an interesting report in histopathology.

![Biopsy from November 2018. (a) Hematoxylin and eosin stain (magnification 400×) showing intra-histiocytic and extracellular yeasts measuring from 3 to 5 microns, resembling *Histoplasma* organisms. (b) Periodic acid--Schiff stain (magnification 400×) showing yeasts measuring 3--12 microns in diameter within histiocytes. (c) Grocott's methenamine silver stain (magnification 400×).](10.1177_2050313X20919600-fig2){#fig2-2050313X20919600}

Prednisone was tapered and itraconazole (200 mg/day) was promptly started. Treatment continued for 4 months leading to complete wound regression and healing of the left arm ([Figure 3](#fig3-2050313X20919600){ref-type="fig"}). He received standard wound care.

![View of the patient's left upper arm 3 months post-treatment.](10.1177_2050313X20919600-fig3){#fig3-2050313X20919600}

A second opinion of the initial biopsy in June 2017 reported the rare presence of PAS-positive yeast ([Figure 4(a)](#fig4-2050313X20919600){ref-type="fig"} and ([b](#fig4-2050313X20919600){ref-type="fig"})) in the original biopsy.

![Biopsy from June 2017. (a) Hematoxylin and eosin stain from the biopsy showing suppurative dermatitis below an ulcer, in which focally a multinucleated histiocyte is visible (magnification 400×). (b) A single PAS-positive yeast organism measuring 4--6 microns found on re-examination (magnification 640×).](10.1177_2050313X20919600-fig4){#fig4-2050313X20919600}

Discussion {#section3-2050313X20919600}
==========

We report a case of chronic *S. schenckii* cutaneous infection initially misdiagnosed as PG due to a lack of tissue culture complemented with overlook in identifying PAS-positive organisms. This led to mistreatment and severe exacerbation of the patient's lesion for 17 months. Re-biopsy showed atypical histologic morphology of *S. schenckii* as hundreds of intra-cytoplasmic yeasts within histiocytes, mimicking *Histoplasmosis* organisms. Tissue culture results confirmed *S. schenckii* infection. This picture is not usually seen in a biopsy of typical sporotrichosis cases and was suspected to be caused by chronic iatrogenic immunosuppression.

*S. schenckii* is an environmentally ubiquitous thermodimorphic fungus existing worldwide in a filamentous form at 25°C and transforming into yeast-like cells at 35°C--37°C. Common sources of infection to trauma-induced wounds include rose thorns, soil, hay, decaying vegetation, plants, animal feces, and zoonotic transmission from cats.^[@bibr10-2050313X20919600]^

Cutaneous manifestations of sporotrichosis include lymphocutaneous, fixed cutaneous, and disseminated cutaneous. In cutaneous infections, a papulonodular lesion develops within 2--4 weeks of inoculation, followed by ulceration and purulent discharge. Lymphocutaneous infections occur with subsequent spread to lymphatic channels and accounts for up to 80% of sporotrichosis infections.^[@bibr11-2050313X20919600],[@bibr12-2050313X20919600]^ Extracutaneous sporotrichosis manifestations including pulmonary, osteoarticular, mucosal, disseminated, and meningeal sporotrichosis have been reported in immunocompromised individuals.^[@bibr11-2050313X20919600],[@bibr13-2050313X20919600]^

An ulcerated lesion may have an infectious or non-infectious differential ([Table 1](#table1-2050313X20919600){ref-type="table"}). Wound culture is the diagnostic gold standard, but may take more than 5 days to grow. A PAS-positive stain was reported in only 3.2%--19.7% of sporotrichosis infections due to low fungal burden in early infections.^[@bibr14-2050313X20919600],[@bibr15-2050313X20919600]^

###### 

Differential diagnosis of cutaneous sporotrichosis.

![](10.1177_2050313X20919600-table1)

  --------------------------------------------------------------------------------------------------------------------
  Infectious causes
  --------------------------------------------------------------------------------------------------------------------
  Fungal\
  • Histoplasmosis\
  • Cryptococcus\
  • Blastomycosis\
  • Coccidioidomycosis

  Bacterial\
  • Cutaneous anthrax (*Bacillus anthracis*)\
  • Pyodermatitis (*Staphylococcus, Streptococcus*)\
  • Cutaneous tuberculosis\
  • Cat-scratch disease (*Bartonella henselae*)\
  • Syphilis (*Treponema pallidum*)\
  • Tularemia (*Francisella tularensis*)\
  • Non-tuberculous mycobacteria (*Mycobacterium avium complex* (MAC), *M. marinum M. chelonae*, and *M. ulcerans*)\
  • Cutaneous nocardiosis (*Nocardia brasiliensis*)\
  • Tertiary syphilis (*Treponema pallidum*)

  Parasitic\
  • Leishmaniasis (*Leishmania braziliensis*)\
  • Cutaneous amebiasis (*Entamoeba histolytica*)

  Non-infectious causes

  • Pyoderma gangrenosum\
  • Osteomyelitis\
  • Cutaneous sarcoidosis\
  • Sweet's syndrome\
  • Wegener's granulomatosis
  --------------------------------------------------------------------------------------------------------------------

Itraconazole is the first-line treatment for cutaneous sporotrichosis infections, with open treatment trials reporting 90%--100% success rate if continued up to 4 weeks after treatment resolution.^[@bibr16-2050313X20919600][@bibr17-2050313X20919600]--[@bibr18-2050313X20919600]^ Liposomal amphotericin B is often used for severe or extracutaneous manifestations.^[@bibr3-2050313X20919600],[@bibr19-2050313X20919600]^ Local heat therapy has also been reported to be effective as temperatures \>38°C minimize sporotrichosis growth.^[@bibr6-2050313X20919600],[@bibr20-2050313X20919600]^

Many reported cases of sporotrichosis misdiagnosed as PG were treated with immunosuppressive treatment leading to exacerbation ([Table 2](#table2-2050313X20919600){ref-type="table"}). Delayed diagnosis led to reports of superinfection, disseminated sporotrichosis, and osteoarticular sporotrichosis.^[@bibr7-2050313X20919600],[@bibr8-2050313X20919600]^ Because both ulcerative PG and fixed cutaneous sporotrichosis occur in absence of lymphatic involvement, the clinical picture is difficult to distinguish.^[@bibr3-2050313X20919600],[@bibr8-2050313X20919600]^ In addition, 50% of sporotrichosis infections are not correlated with a history of trauma, gardening, or rose exposure.^[@bibr2-2050313X20919600]^

###### 

Case reports of sporotrichosis infections misdiagnosed as pyoderma gangrenosum.

![](10.1177_2050313X20919600-table2)

  Author, year                                       Age and sex   History                                                       Risk factors                                   Site of lesion                     What led to initial diagnosis of PG?                                                                                                                                                          Initial management                                                                          Sporotrichosis diagnosis (Method)                                 Treatment
  -------------------------------------------------- ------------- ------------------------------------------------------------- ---------------------------------------------- ---------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ----------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Byrd et al., 2001^[@bibr2-2050313X20919600]^       59 and F      6 months Hx of ulcerated nodule                               Ankle prick by rose thorn                      Right leg                          Unknown, but was diagnosed as PG after ulceration of lesion                                                                                                                                   Prednisone, oral antibiotics, azathioprine, and cyclosporine                                Cutaneous sporotrichosis (Tissue culture, positive PAS stain)     Itraconazole (200 mg/TID) for 18 months
  Yang et al., 2006^[@bibr3-2050313X20919600]^       40 and M      1 year Hx of non-healing ulcer with history of sarcoidosis    Blackberry picking                             Left forearm                       Two previously nondiagnostic biopsies, negative tissue culture, and history of pulmonary sarcoidosis led to suspicion of ulcerative cutaneous sarcoidosis and pyoderma gangrenosum            Prednisone                                                                                  Disseminated cutaneous sporotrichosis (Biopsy and culture)        Itraconazole (200 mg/d) for 2 months
  Lima et al., 2017^[@bibr4-2050313X20919600]^       39 and F      Incomplete response to itraconazole from 2 years ago          Scratched by sporotrichosis-infected cat       Abdomen progressing to right arm   Incomplete response to itraconazole from 2 years ago led to revision of diagnosis to PG                                                                                                       Corticosteroids, immunosuppressive drugs, infliximab, non-opioid analgesics, and morphine   Disseminated cutaneous sporotrichosis (Biopsy, tissue culture)    Liposomal amphotericin B (400 mg/day) for 6 weeks followed by itraconazole (400 mg/d) for 12 months
  Charles et al., 2017^[@bibr5-2050313X20919600]^    57 and F      10 months Hx of three enlarging ulcers after arthropod bite   Trauma                                         Right arm                          Biopsy showed granulomatous reaction, incomplete response to itraconazole, ulcerative characteristic, and severely painful pattern led to presumed diagnosis of PG with secondary infection   Levofloxacin, ceftriaxone, prednisone, penicillin, and topical clobetasol                   Cutaneous sporotrichosis (Tissue culture, positive PAS stain)     Itraconazole (200 mg/d) for 3 months followed by 200 mg/BID
  Takazawa et al., 2018^[@bibr6-2050313X20919600]^   47 and M      4 months Hx of skin ulcer on leg after fall                   Trauma                                         Right lower leg                    Medical history of ulcerative colitis and clinical presentation of skin ulcer                                                                                                                 Topical steroid                                                                             Fixed cutaneous sporotrichosis (Tissue culture, PAS stain, PCR)   Potassium iodide (500 mg) for 2 weeks followed by 1000 mg for 3 weeks
  Saeed et al., 2019^[@bibr7-2050313X20919600]^      35 and F      Fell on right forearm                                         Cat owner, previously worked as a landscaper   Legs, arm, and abdomen             Negative stains and numerous ulcers                                                                                                                                                           Prednisone doxycycline                                                                      Osteoarticular and disseminated sporotrichosis (Tissue culture)   Liposomal amphotericin B for 28 days, itraconazole (200 mg/TID followed by 200 mg/BID). Amphotericin (4 mg/kg/d) for 3 weeks followed by posaconazole (300 mg/d) for 12 months
  White et al., 2019^[@bibr8-2050313X20919600]^      62 and M      1 month Hx of thigh lesion after playing golf                                                                Left thigh                         Atypical presentation ulcer without lymphocutaneous spread                                                                                                                                    Cephalexin for group B streptococcus prednisone, cyclosporine, ustekinumab, and IVIG        Disseminated sporotrichosis (Tissue and blood culture)            Liposomal amphotericin B (5 mg/kg IV daily), posaconazole (300 mg/BID followed by 300 mg/d). Itraconazole (200 mg/q8 h × 9 followed by 200 mg/q12 h) for 10 months after discharge; terbinafine (250 mg/d) later added due to wound progression
  Present case                                       78 and M      No relevant history                                           None                                           Left arm                           Negative PAS stain, and lack of tissue culture                                                                                                                                                Cyclosporine, mycophenolate, IVIG, prednisone, and ustekinumab                              Fixed cutaneous sporotrichosis (Tissue culture)                   Itraconazole (200 mg/d) for 4 months

PG: pyoderma gangrenosum; PAS: periodic acid--Schiff; IVIG: IV immunoglobulin; BID: two times a day; TID: three times a day.

In 2018, Maverakis et al. published revised diagnostic criteria for diagnosing ulcerative PG.8 The major diagnostic criterion of histological presence of neutrophilic infiltrate at the ulcer edge must be met along with four other minor diagnostic criteria ([Table 3](#table3-2050313X20919600){ref-type="table"}). Under previous diagnostic criteria of exclusion, our case would not have satisfied the PG diagnostic criterion as a proper exclusion of infection was not done. However, under the new diagnostic criteria where exclusion of infectious causes is not required, potential for misdiagnosis and treatment exacerbation increases.

###### 

New diagnostic criteria for ulcerative pyoderma gangrenosum.

![](10.1177_2050313X20919600-table3)

  --------------------------------------------------------------------------------------------------------------------
  Major diagnostic criterion---*Must be met*:\
   Biopsy of ulcer edge demonstrates neutrophilic infiltrate

  Minor diagnostic criterion---*At least four must be met*:\
   Pathergy(ulcer occuring at the site of trauma) Exclusion of infection via histological stains and tissue culture\
   Pathergy^[a](#table-fn3-2050313X20919600){ref-type="table-fn"}^\
   History (personal or family) of inflammatory bowel disease or inflammatory arthritis\
   History of papule pustule, or vesicle that rapidly ulcerated\
   Peripheral erythema, undermining border, and tenderness at site of ulceration\
   Multiple ulcerations with at least one occurring on anterior lower leg\
   Cribriform or "wrinkled paper" scar(s) at site of healed ulcer\
   Decrease in ulcer size within 1 month of initiating immunosuppressive medication(s)
  --------------------------------------------------------------------------------------------------------------------

Source: Modified from Maverakis et al. (2018).

Ulcers occurring at trauma sites should extend past the area of trauma.

Ultimately, this case highlights the importance of tissue culture in excluding infectious causes before diagnosing PG and presents an atypical *S. schenckii* morphology mimicking *Histoplasma* organisms in chronically immunosuppressed infections.
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